.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Daiichi Sankyo
Citi
Colorcon
Dow
AstraZeneca
Merck
Novartis
Deloitte
Farmers Insurance

Generated: September 25, 2017

DrugPatentWatch Database Preview

INFLAMASE MILD Drug Profile

« Back to Dashboard

Which patents cover Inflamase Mild, and what generic Inflamase Mild alternatives are available?

Inflamase Mild is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in INFLAMASE MILD is prednisolone sodium phosphate. There are eighty-six drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the prednisolone sodium phosphate profile page.

Summary for Tradename: INFLAMASE MILD

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list52
Clinical Trials: see list3,411
Patent Applications: see list3,578
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:INFLAMASE MILD at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis
INFLAMASE MILD
prednisolone sodium phosphate
SOLUTION/DROPS;OPHTHALMIC080751-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Medtronic
Boehringer Ingelheim
Moodys
Accenture
Merck
QuintilesIMS
Novartis
Chinese Patent Office
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot